亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會(huì)員登錄|免費(fèi)注冊(cè)|忘記密碼|管理入口 返回主站||保存桌面|手機(jī)瀏覽|聯(lián)系方式|購物車
企業(yè)會(huì)員第1年

張家港保稅區(qū)凱利特化工有限公司  

原料藥,醫(yī)藥中間體,精細(xì)化學(xué)品

搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
聯(lián)系方式
  • 聯(lián)系人:姚廣
  • 電話:18252995085
  • QQ:524465307
站內(nèi)搜索
 
榮譽(yù)資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應(yīng)產(chǎn)品 > 4-[(4-甲基哌嗪-1-基)甲基]苯甲酸二鹽酸鹽
4-[(4-甲基哌嗪-1-基)甲基]苯甲酸二鹽酸鹽
單價(jià) 面議對(duì)比
詢價(jià) 暫無
發(fā)貨 江蘇蘇州市付款后3天內(nèi)
過期 長期有效
更新 2012-08-30 13:44
 
詳細(xì)信息

中文別名:4-((4-甲基哌嗪-1-)甲基)苯甲酸二鹽酸鹽水合物;

4-(4-甲基哌嗪-1-甲基)苯甲酸鹽酸鹽;

4-[(4-甲基哌嗪-1-)甲基]苯甲酸二鹽酸鹽

英文別名:4-[(4-Methyl-1-piperazinyl)methyl]benzoic acid dihydrochloride hemihydrate;

CAS號(hào):106261-49-8

分子式:C16H13N5O2

分子量:307.3067

用途: 甲磺酸伊馬替尼中間體

含量:≥99.0%

©2025 張家港保稅區(qū)凱利特化工有限公司 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:14771  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |